Where data means more

“

Ashley ZehnderCEO-Fauna Bio

“Fauna Bio has been working in partnership with Excelra since 2020 to curate functional datasets from extremely adapted species, human data and other core datasets that power our differentiated platform. Excellent AI discovery relies on clean, well-curated datasets. Having data partners with rigorous scientific training and domain expertise partnered with our scientists enables us to do the work that we do and build our discovery and therapeutic pipelines for ourselves and for our pharma partners. We couldn't do the work that we do without Excelra!”

“

Peter GuzzoVP (Head of Drug Discovery)-VARIATIONAL AI

“Drug discovery is a complex, time-consuming process that entails multi-parameter optimization of molecular properties. GOSTAR’s curated drug discovery data is a key building block for our proprietary, generative AI technology, Enki. Enki performs multi-parameter optimization to accelerate the design of novel and selective compounds for important therapeutic targets.”

“

Fred ManbyCo-founder and CTO, Lambic Therapeutics

“Drug discovery is a challenge of optimizing dozens of molecular attributes simultaneously. Incorporating high-quality, annotated, and comprehensive datasets from GOSTAR™ is crucial for training our data-efficient physics-based AI models and supplementing them with program-specific data from our platform helps us achieve the desired attributes of a compound. Leveraging such data makes the process more time and resource-efficient, aids across a very wide range of relevant endpoints for early discovery and enables the design of novel therapeutics.”